TABLE 5.
Quantification of enzymatic degradation of meropenem products by mDHP-I, determined by HPLC-UV and microbiological assaya
Assay and reaction time (h) | Fraction of initial meropenem concn remaining (%) |
||||||
---|---|---|---|---|---|---|---|
Control | Initial 125 mg/liter |
Initial 250 mg/liter |
Initial 500 mg/liter |
||||
iMer | gMer-A | iMer | gMer-A | iMer | gMer-A | ||
HPLC-UV | |||||||
0.08 | 99 | 89 | 65 | 86 | 48 | 96.4 | 51 |
0.5 | 98.3 | 87 | 63 | 82 | 44 | 94 | 47 |
1.0 | 96 | 49 | 25 | 39 | 26 | 73 | 37 |
1.5 | 96 | 23 | 17 | 27 | 14 | 57 | 8 |
4.0 | 92 | 10 | 10 | 8 | 8.4 | 41 | 0 |
4.5 | 92 | 10 | 8 | 6 | 4 | 0 | 0 |
Microbiological assay | |||||||
0.08 | 96 | 92 | 45 | 88 | 45 | 89 | 64 |
0.5 | 94 | 94 | 45 | 88 | 43 | 89 | 60 |
1.0 | 94 | 64 | 30 | 31 | 17 | 35 | 14 |
1.5 | 94 | 48 | 23 | 20 | 12 | 22 | 17 |
4.0 | 88 | 15 | 0 | 6 | 6 | 7 | 5 |
4.5 | 88 | 0 | 0 | 6 | 6 | 5 | 5 |
The enzymatic reaction was allowed to take place for 5 min at 37°C before taking the first sample for analysis; the control sample (iMer, 500 mg/liter) was incubated in sterile saline without the enzyme. The data are presented as the percentage of each initial concentration of meropenem (125, 250, or 500 mg/liter).